520 related articles for article (PubMed ID: 26653875)
21. Insights into colloidal nanoparticle-protein corona interactions for nanomedicine applications.
Martínez-Negro M; González-Rubio G; Aicart E; Landfester K; Guerrero-Martínez A; Junquera E
Adv Colloid Interface Sci; 2021 Mar; 289():102366. PubMed ID: 33540289
[TBL] [Abstract][Full Text] [Related]
22. Protein corona-mediated targeting of nanocarriers to B cells allows redirection of allergic immune responses.
Shen L; Tenzer S; Storck W; Hobernik D; Raker VK; Fischer K; Decker S; Dzionek A; Krauthäuser S; Diken M; Nikolaev A; Maxeiner J; Schuster P; Kappel C; Verschoor A; Schild H; Grabbe S; Bros M
J Allergy Clin Immunol; 2018 Nov; 142(5):1558-1570. PubMed ID: 29382591
[TBL] [Abstract][Full Text] [Related]
23. Formation of Protein Corona on Nanoparticle Affects Different Complement Activation Pathways Mediated by C1q.
Ding T; Sun J
Pharm Res; 2019 Dec; 37(1):10. PubMed ID: 31872347
[TBL] [Abstract][Full Text] [Related]
24. Mechanistic Understanding of Protein Corona Formation around Nanoparticles: Old Puzzles and New Insights.
Nienhaus K; Nienhaus GU
Small; 2023 Jul; 19(28):e2301663. PubMed ID: 37010040
[TBL] [Abstract][Full Text] [Related]
25. Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging.
Bhaskar S; Tian F; Stoeger T; Kreyling W; de la Fuente JM; Grazú V; Borm P; Estrada G; Ntziachristos V; Razansky D
Part Fibre Toxicol; 2010 Mar; 7():3. PubMed ID: 20199661
[TBL] [Abstract][Full Text] [Related]
26. Nanotoxicology: advances and pitfalls in research methodology.
Azhdarzadeh M; Saei AA; Sharifi S; Hajipour MJ; Alkilany AM; Sharifzadeh M; Ramazani F; Laurent S; Mashaghi A; Mahmoudi M
Nanomedicine (Lond); 2015; 10(18):2931-52. PubMed ID: 26370561
[TBL] [Abstract][Full Text] [Related]
27. Engineering a Nano/Biointerface for Cell and Organ-Selective Drug Delivery.
Song D; Xu Q
Langmuir; 2022 Aug; 38(30):9092-9098. PubMed ID: 35852946
[TBL] [Abstract][Full Text] [Related]
28. Recent Advances in Understanding the Protein Corona of Nanoparticles and in the Formulation of "Stealthy" Nanomaterials.
Rampado R; Crotti S; Caliceti P; Pucciarelli S; Agostini M
Front Bioeng Biotechnol; 2020; 8():166. PubMed ID: 32309278
[TBL] [Abstract][Full Text] [Related]
29. Protein Corona-Enabled Systemic Delivery and Targeting of Nanoparticles.
Chen D; Ganesh S; Wang W; Amiji M
AAPS J; 2020 Jun; 22(4):83. PubMed ID: 32495039
[TBL] [Abstract][Full Text] [Related]
30. In Situ Characterization of Protein Adsorption onto Nanoparticles by Fluorescence Correlation Spectroscopy.
Shang L; Nienhaus GU
Acc Chem Res; 2017 Feb; 50(2):387-395. PubMed ID: 28145686
[TBL] [Abstract][Full Text] [Related]
31. Recent advances in the analysis of nanoparticle-protein coronas.
Ovais M; Nethi SK; Ullah S; Ahmad I; Mukherjee S; Chen C
Nanomedicine (Lond); 2020 Apr; 15(10):1037-1061. PubMed ID: 32248745
[TBL] [Abstract][Full Text] [Related]
32. The Yin and Yang of the protein corona on the delivery journey of nanoparticles.
Wang YF; Zhou Y; Sun J; Wang X; Jia Y; Ge K; Yan Y; Dawson KA; Guo S; Zhang J; Liang XJ
Nano Res; 2023; 16(1):715-734. PubMed ID: 36156906
[TBL] [Abstract][Full Text] [Related]
33. Protein corona: Friend or foe? Co-opting serum proteins for nanoparticle delivery.
Kim W; Ly NK; He Y; Li Y; Yuan Z; Yeo Y
Adv Drug Deliv Rev; 2023 Jan; 192():114635. PubMed ID: 36503885
[TBL] [Abstract][Full Text] [Related]
34. Nano-bio interface between human plasma and niosomes with different formulations indicates protein corona patterns for nanoparticle cell targeting and uptake.
Imperlini E; Celia C; Cevenini A; Mandola A; Raia M; Fresta M; Orrù S; Di Marzio L; Salvatore F
Nanoscale; 2021 Mar; 13(10):5251-5269. PubMed ID: 33666624
[TBL] [Abstract][Full Text] [Related]
35. Toward a molecular understanding of nanoparticle-protein interactions.
Treuel L; Nienhaus GU
Biophys Rev; 2012 Jun; 4(2):137-147. PubMed ID: 28510093
[TBL] [Abstract][Full Text] [Related]
36. How protein coronas determine the fate of engineered nanoparticles in biological environment.
Capjak I; Goreta SŠ; Jurašin DD; Vrček IV
Arh Hig Rada Toksikol; 2017 Dec; 68(4):245-253. PubMed ID: 29337683
[TBL] [Abstract][Full Text] [Related]
37. Secreted protein eco-corona mediates uptake and impacts of polystyrene nanoparticles on Daphnia magna.
Nasser F; Lynch I
J Proteomics; 2016 Mar; 137():45-51. PubMed ID: 26376098
[TBL] [Abstract][Full Text] [Related]
38. Unraveling the Effect of Breast Cancer Patients' Plasma on the Targeting Ability of Folic Acid-Modified Chitosan Nanoparticles.
Nemati M; Bani F; Sepasi T; Zamiri RE; Rasmi Y; Kahroba H; Rahbarghazi R; Sadeghi MR; Wang Y; Zarebkohan A; Gao H
Mol Pharm; 2021 Dec; 18(12):4341-4353. PubMed ID: 34779630
[TBL] [Abstract][Full Text] [Related]
39. Biomolecular Corona Affects Controlled Release of Drug Payloads from Nanocarriers.
Sharifi S; Caracciolo G; Mahmoudi M
Trends Pharmacol Sci; 2020 Sep; 41(9):641-652. PubMed ID: 32713606
[TBL] [Abstract][Full Text] [Related]
40. Nano-bio interactions in mRNA nanomedicine: Challenges and opportunities for targeted mRNA delivery.
Saiding Q; Zhang Z; Chen S; Xiao F; Chen Y; Li Y; Zhen X; Khan MM; Chen W; Koo S; Kong N; Tao W
Adv Drug Deliv Rev; 2023 Dec; 203():115116. PubMed ID: 37871748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
